Forbion’s new €75M fund; Cara Therapeutics to cut workforce after trial failure

Plus, news about Cinclus Pharma, Biophytis and Blanver:

Forbion’s new fund: The Dutch VC firm’s BioEconomy Fund I closed €75 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Merck KGaA plans China submission after late-stage win for tumor drug

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 13, 2024

First At-Home Test for Chlamydia and Gonorrhea Authorized by FDA

The FDA on Wednesday granted marketing authorization to the first chlamydia and gonorrhea test that allows for at-home sample collection. Intended for adults, the over-the-counter

November 17, 2023

Postoperative Urinary Retention Common After Hernia Surgery

Postoperative urinary retention (POUR) was common following inguinal hernia surgery in an international cohort study. Among 4,151 adults across 32 countries, incidence of needing bladder

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.